Table.

Summary of Benefits to U.S. Science, Academic Institutions, Investigators, and Others From Engaging in Global Noncommunicable Disease Research

Science	Academic Institutions	Investigators	Others
Reverse innovation and opportunities for implementation science	Training opportunities for early career investigators	Personal enrichment	US State Department: soft power influence through health diplomacy
Unique environmental exposures and doses	Improve reputation and prestige, and thus the strength of faculty and student applicants	Expanded pool of mentors	Industry: help feed pipeline of young investigators; efficiency of clinical trials; support labor force for US industries abroad
Genetic diversity	Create sense of solidarity among faculty	Develop leadership skills	Global academic partners: universities working together to develop research infrastructure and skills
Immigrant and minority health	Engage in university mission	Establish partnerships that could last decades	Research investments can be sources of revenue through patentable ideas
US military, expatriate, and traveler health	Increase visibility with other organizations	Platform for early career investigators to develop their own pathways
Standardization and validation of different tools in diverse populations	Partnering with other strong institutions in low- and middle-income countries extends reach of limited resources	Interdisciplinary exchange of ideas, new perspectives, people
Access to diseases or advanced disease stages that are rare in US	Diversify student body, trainees, and faculty from low- and middle-income countries
Unique opportunity to study interactions with infectious diseases	Increase breadth of diseases studied and appeal to prospective students and faculty
Basic science research cheaper	Research drives creativity and innovation in healthcare
Drug discovery (traditional medicines)